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RtMS parameters in tinnitus trials: 
a systematic review
Stefan Schoisswohl  1,4, Kushal Agrawal  2,4, Jorge Simoes1,4, Patrick Neff1,3, 
Winfried Schlee1,4, Berthold Langguth1,4 & Martin Schecklmann1,4
Over the past few years extensive body of research was produced investigating the effects of repetitive 
transcranial magnetic stimulation (rtMS) for the treatment of chronic tinnitus with heterogeneous 
results. This heterogeneity is exemplified by two recently published large-scale clinical trials 
reporting different outcomes. Technical aspects of rTMS were suspected as a potential source for this 
incongruency. The aim of this systematic review is to examine the overall efficacy as well as to identify 
possible technical factors relevant for the effectiveness of rTMS tinnitus trials. Via a literature search 
appropriate original research papers were identified and rTMS parameters were extracted from each 
study arm for subsequent statistical analysis with respect to observed effects (significant vs. not 
significant pre-post rTMS effects). Our findings indicate that verum rTMS is superior to sham rTMS as 
demonstrated by the proportion of significant pre-post contrasts. Some relevant rTMS parameters 
(e.g., pulse waveform) are not reported. Lower rTMS stimulation intensity was associated with 
significant effects in verum rTMS arms. An additional stimulation of the DLPFC to the temporal cortex 
was not found to promote efficacy. Future research should consider differential effects of rTMS induced 
by technical parameters and strive for an exhaustive reporting of relevant rtMS parameters.
Chronic subjective tinnitus is defined as the perception of a sound, such as ringing or buzzing, without the pres-
ence of an external or internal source1 with a duration of at least three months2. Approximately 10–15% of people 
living in industrial countries are affected by such persistent sounds and up to now, there is no available cure3. 
Etiology of tinnitus seems to be very heterogeneous, though in most cases it occurs after cochlear damages fol-
lowing noise trauma or hearing loss in general4. It is assumed, that as a consequence of diminished or missing 
acoustic input and the ensuing deprivation of neural input in the auditory pathways, pathological brain changes 
occur and the “phantom sound”, called tinnitus is generated5,6. From a neurophysiological perspective subjective 
tinnitus is therefore associated with altered neural activity along the auditory pathway7 and hyperactivity in audi-
tory brain areas8,9 as well as non-auditory brain areas10. As noted by Theodoroff and Folmer11, these given patho-
logical neural circumstances represent a significant leverage point for the application of recent neuromodulation 
techniques, in particular repetitive transcranial magnetic stimulation (rTMS).
15 years ago, low-frequency rTMS of the left auditory cortex was introduced as a new possibility to treat tinni-
tus based on the rationale to reduce the over-activated left temporal cortex12,13. Since that time a bulk of trials and 
also several reviews were published with heterogeneous evaluation of the putative efficacy of rTMS for the treat-
ment of tinnitus. The findings and conclusions of clinical trials with rTMS in tinnitus manifest to be diverse and 
are particularly denoted with e.g. high interindividual variability, a lack of sham-controlled trials and small effect 
sizes14–16. An early review from Langguth et al. in 2008 resumed a “promising potential of rTMS for therapeutic 
management of tinnitus”17. This conclusion is supported by other reviews, which report rTMS as a new therapeu-
tic tool for tinnitus15, with potential efficacy18, some given evidence19 or even significant medium to large effect 
sizes as shown by a meta-analysis20. Furthermore, left temporal low frequency rTMS was declared with a Level 
C recommendation (possible efficacy) in a consensus statement21. Other reviews indicated “very limited support 
for the use of low-frequency rTMS for the treatment of patients with chronic tinnitus”22 or a general tendency to 
not recommend rTMS for tinnitus23.
Beside heterogeneity in the evaluation of the efficacy of rTMS one aspect past reviews have in common, is a 
demand for the implementation of randomized, sham-controlled clinical trials with an appropriate sample size. 
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To the best of our knowledge, two such trials were conducted and published. The ongoing discourse regarding 
rTMS in tinnitus proceeds by these two clinical trials with an almost identical methodological design and dif-
ferent reported results. Folmer and colleagues24 were able to show a significant effect of a sham-controlled 1 Hz 
rTMS protocol over the auditory cortex on the improvement of tinnitus severity in a study with 64 patients. In 
contrast, a recent published multi-center study from Landgrebe et al.25 involving 146 patients could not report 
any improvements as a consequence of rTMS even by investigating a larger sample. It was discussed in subsequent 
letters to the editors, that differences in samples (e.g., sample size), used trial design (e.g., outcome measures), 
but also technical parameters of rTMS (e.g., TMS devices) might be responsible for the conflicting results26,27. In 
the case of used TMS devices the direction of current flow differs by default28, which was shown to be critical for 
the induction of neuroplasticity21,29. Parameter space of technical aspects of rTMS is very large and all of them 
seem to be relevant for neurophysiological effects of rTMS30. As early findings indicate and thus as a rule of 
thumb, low stimulation frequency decreases (≤1 Hz) and high stimulation frequency increases cortical excitabil-
ity (≥5 Hz)31,32. In the same manner, the number of pulses delivered per session or the stimulation intensity used, 
might be essential for the effectiveness of rTMS33,34.
Even if there are plenty of previous reviews, they remain narrow in focus dealing only with effectiveness in 
general or just patient characteristics, but do not take the rTMS parameters into account. Hence, the aim of this 
systematic review is to examine previous research concerning daily rTMS in tinnitus to present a statistical over-
view of general effectiveness of rTMS as indicated by verum-sham contrast and to investigate the influence of 
rTMS parameters on the effect of verum rTMS in tinnitus.
Materials and Methods
protocol and registration. The review for this paper was conducted according to the guidelines for 
“Preferred Reporting Items for Systematic Reviews and Meta-Analysis” (PRISMA35; see Supplemental Material 1). 
Moreover, the details of the protocol for this review were registered in the International Prospective Register of 
Systematic Reviews, PROSPERO (CRD42018099744).
Search strategy, study selection and data collection. A systematic literature search was conducted in 
May 2018 by two independent individuals using the electronic research databases “PubMed” and “ScienceDirect” 
with the keywords “tinnitus” and “transcranial”. Figure 1 provides an overview of the literature identification 
process by the means of an adapted flow diagram originally provided by the PRISMA guidelines35. In order to 
identify a maximum quantity of research papers, the keywords were applied to all possible search fields. The utili-
zation of “PubMed” resulted in N = 317 potential papers, the search with the database “ScienceDirect” was able to 
find N = 1.033 articles. An initial screening of the search outcomes was executed by examining the title as well as 
the corresponding abstracts with respect to previously defined inclusion criteria: original research data; applica-
tion of rTMS; repeated sessions; focus on chronic tinnitus. N = 68 from PubMed and n = 14 from ScienceDirect 
appropriate research papers could be identified. Hereinafter, the results of both search engines were checked 
for duplicates and merged to a consolidated table with n = 68 articles with all publications of the ScienceDirect 
search included in the PubMed search. In a next step, the papers were resurveyed in full text, to ascertain, if the 
studies used data which was already published. As a result, n = 12 papers had to be excluded from our review. 
Towards the end of the literature identification process, an additional paper was added as detected by regular 
PubMed searches. Consequently, the final quantity of records for this review and subsequent analysis consisted 
of n = 57 research papers. In order to deploy statistical analysis, important rTMS parameters were extracted from 
the records for each verum study arm separately. Thus, the parameter extraction of one single paper could even-
tuate in multiple study arms for our analysis. Sham arms were not included as we were interested in the effects of 
rTMS parameters on treatment efficacy. Number of verum and sham arms were counted for estimation of overall 
rTMS efficacy (see statistics).
Parameters of interest were: manufacturer of the TMS device; type of TMS device; pulse waveform; coil type; 
coil orientation; stimulation position; stimulation laterality of auditory cortex stimulation (unilateral or bilateral); 
unilateral stimulation index (extracted by a calculated ratio for the stimulated hemisphere (left = 0, right = 1)); 
the definition of the stimulated hemisphere with respect to tinnitus laterality; stimulation frequency (Hz) (con-
densed to inhibitory or excitatory frequency protocols for analysis); stimulation intensity (% of motor threshold); 
mean motor threshold (%); motor threshold determination method (electromyography (EMG)/visual); number 
of sessions; overall pulses per session over auditory and prefrontal cortical areas; pulses per session over auditory 
cortical areas; overall total pulses over auditory and prefrontal cortical areas (calculated as the number of pulses 
per session * number of sessions); total pulses over auditory cortical (defined as the number of auditory pulses 
per session * number of sessions); use of a neuronavigation system (yes/no); additional stimulation (e.g., fron-
tal stimulation additionally to auditory cortex stimulation; stimulation parameters were extracted equally; cf. 
Supplemental Material 2). Further study-specific information like type of additional treatment, study design or 
used outcome measurements were also extracted from the records, simply to provide an overview and were not 
considered for statistical analysis.
As no study arm reported the used pulse waveform, we decided to perform statistical analysis for this purpose 
with the default waveform of the used TMS devices. The information was gathered from user manuals and by 
contacting the manufacturers of the devices or the authors of the papers, respectively. Our dependent variable of 
interest was the reported effect of each of the study arms dichotomized to “significant” and “not significant”, as 
most papers did not report effect sizes. Since only N = 38 study arms provided information about the definition 
of a primary outcome instrument, a study arm was declared as significant, if 50% or more of the used outcome 
measurements were reported as “significant”. In case of a lack of information concerning relevant parameters or 
outcomes, the term “not reported” was used and was not considered in the definition of the reported effect.
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Data analysis. Statistical analysis was performed with the statistic software R (R version 3.4.3; R Foundation 
for Statistical Computing, Austria; packages “tidyverse and “gmodels”) and focused on the change of symptoms 
from pre to post treatment of each extracted study arm. For all analyses, we concentrated on trials using stimu-
lation of the temporal or temporoparietal cortex as most studies primarily stimulated these areas (for details see 
results section) and thus stimulation positions restricted solely to areas outside the temporal region were excluded 
(three study arms including prefrontal cortex). For seven study arms no information was provided about whether 
pre to post rTMS changes were significant or not. Therefore, n = 10 study arms were excluded, resulting in 74 
study arms included in statistical analyses (cf. Fig. 1). Missing values, “not-reported” effects or information only 
provided in certain ranges (e.g., pulses per session 1800–3000) were excluded for each parameter analysis indi-
vidually. Parameters were not analyzed, if 30% of the investigated arms did not provide data. Associations of 
categorical data with the reported effects (significant vs. not significant) were calculated with χ2-tests and Fisher’s 
exact tests in the case of cell frequencies below 5. To evaluate differences in parametric variables regarding the 
Figure 1. Review Procedure. The procedure of this systematic review from literature identification to the 
final number of verum rTMS study arms for statistical analysis is depicted as a flow diagram adapted from the 
PRISMA guidelines35.
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given effect, Mann-Whitney U-tests for independent samples were computed. Significance level was defined as 
p ≤ 0.05 and reported uncorrected for multiple comparisons.
Results
The extraction of relevant parameters from N = 57 research papers resulted in overall N = 74 study arms for 
which statistical comparisons from pre to post rTMS treatment were done. A detailed overview of the descriptive 
statistics of rTMS parameters of the single study arms can be found in Supplemental Material 2. Out of 74 study 
arms used for statistics, 56 arms reported significant effects (76%). In order to ascertain whether the efficacy of 
verum rTMS is higher in contrast to sham rTMS, we statistically compared the quantity of reported significant 
and not significant results of verum study arms with those of available 22 sham arms (5 significant; 23%). A 
χ2-test indicated a significant association of the type of study arm (verum or sham) and rTMS efficacy (pre-post 
change significant or not) showing a superiority of verum in contrast to sham rTMS (p < 0.05). Table 1 shows the 
results of the association of technical rTMS parameters with efficacy as indicated by pre-post changes in verum 
study arms. Analyses of parametric data revealed that the group of significant study arms, showed lower stimula-
tion intensity (about 6.5% stimulator output) in contrast to not significant arms (cf. Fig. 2). Out of 18 study arms 
utilizing a stimulation intensity lower than 110%, 94.44% reported significant results. Whereas, in case of ≥110% 
stimulation intensity (two study arms with 120% stimulation intensity; one significant, one not significant), 
68.00% of 50 study arms state significant findings.” To exclude a potential confounder caused by studies applying 
continuous theta burst stimulation (cTBS) using commonly lower stimulation intensities, we investigated a pos-
sible association of cTBS or rTMS with reported effects. Our results show no significant association (proportion 
of significant studies did not differ between cTBS and rTMS studies; cf. Table 1), indicating an exclusion of this 
potential bias in our stimulation intensity results.
With respect to number of pulses, significant study arms used less pulses. Since the number of pulses was only 
significant for overall pulses per session, we compared the reported effects of study arms which used an additional 
DLPFC stimulation (n = 16) with those free of any additional stimulation, as DLPFC stimulation in addition to 
auditory cortex stimulation might result more applied pulses. Indeed, a significant difference was found in the 
used number of pulses between arms with additional prefrontal stimulation (3056.25 ± 871.78) and those with 
only temporal rTMS (1672.28 ± 723.44), U = 108.50, p < 0.01. As pointed out in Table 1, a χ2-test found a sig-
nificant association between the use of an additional DLPFC stimulation and whether or not the effect of rTMS 
was significant. Since 80.70% of the study arms without an additional stimulation of the DLPFC report significant 
results, whereas only 56.25% of the study arms with an additional stimulation show significant effects, our find-
ings suggest no benefit of an additional DLPFC stimulation, rather the opposite seems to pertain.
In order to preclude a potential publication bias caused by a possible high quantity of significant or not signifi-
cant results published in certain years (e.g., more significant studies in early years and more not significant studies 
in late years36), publication years of 57 study arms with solely auditory cortex rTMS were considered for statistical 
analysis to check if there is a mean difference between significant and not significant effects. No significant differ-
ence was found, perpending an exclusion of a publication bias, U = 241.50, p = 0.82. Figure 3 presents a summary 
of the quantity of published auditory cortex rTMS trial arms for each year subdivided by the reported effect.
All other parametric parameters were not significant. Mean motor threshold was not analyzed due to more 
than 30% of missing data (n = 65).
Analysis of categorical data showed no significant associations e.g. between the manufacturer of the TMS 
device (Magstim vs. MagVenture/Medtronic; number of other manufacturers were too low to include in analy-
sis) or the default waveform of the system (biphasic cosine vs. biphasic sine). Coil orientation was not analyzed, 
because it was not reported in 34 study arms. Likewise, the type of coil was not included in statistical analysis, 
since 93.2% of examined arms used a figure-of-eight coil. Table 2 provides an overview over the missing informa-
tion for all parameters separated for significant and not significant study arms.
Discussion
Due to ongoing discussions about the effectiveness of rTMS in chronic tinnitus and recently initiated consid-
erations if beside methodological also technical parameters of rTMS affect treatment efficacy, we conducted a 
systematic review of previous research concerning daily rTMS in tinnitus with the aim to present a statistical 
overview of general effectiveness of rTMS and to identify the influence of rTMS parameters on the consequences 
of verum rTMS in tinnitus.
With respect to the question if rTMS is generally effective as a treatment in tinnitus, we demonstrated that 
the proportion of significant pre-post comparisons is significantly higher for verum in contrast to sham arms. 
The chosen statistical strategy with observed effects dichotomized to “significant” and “not significant” is limited. 
Meta-analyses are rather suitable as a statistical approach to resolve this question. Furthermore, the quantity of 
eligible studies might be too low for valid analysis at this stage. Despite two recently published large trials with 
contradictory findings24,25, the debate on recommendation of auditory cortex rTMS for the treatment of chronic 
tinnitus is still not completed.
We explored two main associations of technical parameters on rTMS efficacy. First, we found that a lower stim-
ulation intensity was associated with significance in the investigated study arms. This finding is in contrast to ear-
lier work in depression and basic research concerning the motor cortex, which suggested a linear dose-response 
relationship, e.g. better treatment response34,37 or an increased influence on motor evoked potentials (MEPs)33,38 is 
associated with higher stimulation intensity. A clarification of the detected reversed impact appears to be difficult. 
One feasible explanation for this could be, that the stimulation intensity generates the intended consequences 
only up to a certain extent and then the effect either disappears or inverts. Similar changes are observed by the 
use of cTBS, which is also known to generate inhibitory effects such as 1 Hz rTMS. Applied at higher stimulation 
intensities, the inhibitory effects shift to excitatory39,40. These observations somewhat corroborate our findings, 
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although with our collected data and statistical analysis we are not able to make a statement about possible excit-
atory effects of high stimulation intensities.
A further possible explanation could be related to skull thickness. Compared to the rest of the cranium, the 
average bone thickness over temporal parts is described as the thinnest41. Due to the location of the primary 
motor cortex under thicker bones, namely the interface of the frontal and parietal osseous, the motor threshold 
at this position might be an insufficient point of reference for the determination of the stimulation intensity for 
other stimulation positions. With respect to our results, a high intensity rTMS over thinner temporal bones might 
result in some kind of hyperstimulation which may induce contrary effects as argued above. Higher stimulation 
intensity potentially caused by visual determination of the motor threshold42 as well as a lower intensities caused 
by cTBS were excluded as shown by our analysis (cf. results section).
rTMS Parameter
Significant Study Arms
Not significant Study 
Arms
p
n = 56 (75.68%) n = 18 (24.32%)
N (%) N (%)
Manufacturer TMS device
   Magstim 14 (77.78) 4 (22.22)
   MagVenture/Medtronic 34 (72.37) 13 (27.66) 0.76
Default waveform
   Biphasic cosine 16 (80.00) 4 (20.00)
   Biphasic sine 36 (72.00) 14 (28.00) 0.56
Stimulation position
   Temporal cortex 32 (78.05) 9 (21.95)
   Temporo-parietal cortex 23 (71.88) 9 (28.12) 0.54
Auditory cortex stimulation laterality
   Bilateral 5 (66.67) 1 (16.67)
   Unilateral 50 (74.73) 17 (25.37) >0.99
Auditory cortex stimulation hemisphere
   Left 36 (70.59) 15 (29.41)
   Other (contralateral, ipsilateral, bilateral, left or right) 19 (86.36) 3 (13.64) 0.24
Stimulation frequency
   Inhibitory (1 Hz, cTBS) 49 (73.13) 18 (26.87)
   Excitatory (10 Hz, 25 Hz) 6 (100.00) 0 (0.00) 0.33
Stimulation type
   cTBS 4 (80.00) 1 (20.00)
   rTMS (1 Hz, 10 Hz, 25 Hz) 50 (73.53) 18 (26.47) 0.33
Motor threshold determination method
   EMG 36 (75.00) 12 (25.00)
   Visual 10 (76.92) 3 (23.08) >0.99
Neuronavigation
   Yes 17 (73.91) 6 (26.09)
   No 38 (76.00) 12 (24.00) 0.85
Prefrontal stimulation in addition to auditory cortex stimulation
   Additional prefrontal stimulation 9 (56.25) 7 (43.75)
   No additional prefrontal stimulation 46 (80.70) 11 (19.30) 0.04*
M ± SD M ± SD p
Stimulation hemisphere - auditory cortical areas (left = 0; 
right = 1)
0.12 ± 0.22
(n = 49)
0.07 ± 0.21
(n = 17) 0.66
Stimulation intensity (%) 103.53 ± 10.7(n = 51)
110.00 ± 3.54
(n = 17) 0.02*
Number of sessions 8.47 ± 3.38(n = 55)
9.22 ± 4.76
(n = 18) 0.80
Overall pulses per session − auditory and prefrontal cortical areas 1807.64 ± 838.04(n = 55)
2488.89 ± 1095.92
(n = 18) 0.03*
Pulses per session − auditory cortical areas 1624.00 ± 671.85(n = 55)
1877.78 ± 662.04
(n = 18) 0.21
Overall total pulses − auditory and prefrontal cortical areas 
(pulses per session × number of sessions)
16003.64 ± 11016.50
(n = 55)
22333.33 ± 13266.50
(n = 18) 0.07
Total pulses − auditory cortical areas (pulses per session × 
number of sessions)
14485.45 ± 9962.53
(n = 55)
17277.78 ± 9730.52
(n = 18) 0.20
Table 1. Descriptive and statistical data of 74 study arms. *p ≤ 0.05.
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Secondly, the present systematic review indicates, that the lower number of pulses, including auditory and pre-
frontal cortical areas (per session and also for the whole trial), the more significant study arms were found. With 
regard to TBS, past research already investigated the effects of longer stimulation protocols with the insight that 
a prolongation of the stimulation per se does not lead to an improvement. A doubling of the stimulation length 
induced reversed after-effects e.g. inhibitory became excitatory43. For rTMS, a meta-analysis reported similar 
results, indicating a smaller number of pulses per session related to antidepressant mechanism of action44. The 
authors of this meta-analysis refer to other conducted meta-analyses with no such association – the key role of the 
quantity of pulses remains to be clarified. The same applies for the field of tinnitus. Former studies observed a sub-
stantial improvement in tinnitus-related outcome measurements with the usage of a higher number of pulses45,46. 
In contrast our investigation suggests the complete opposite.
It is very probable, that the effect is conceivably caused by an additional stimulation of the DLPFC, which 
features significant more pulses per session (cf. results section). Based on the rationale that via prefrontal rTMS 
anti-depressant effects take place21, an assumed interplay of tinnitus and depression47,48 and the involvement of 
prefrontal areas in auditory gating and tinnitus, combined frontal and temporal rTMS was proposed for more 
efficient suppression of tinnitus symptoms49–51. In contrast, our results are not in accordance with these findings. 
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Figure 2. Reported Effect & Stimulation Intensity. The distribution of the stimulation intensity used by study 
arms separated for the reported results (significant effects N = 51; not significant effects N = 17).
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Figure 3. Year & Number of published Study Arms. For each year, the number of published study arms with an 
exclusively auditory cortex rTMS grouped for significant and not significant reported effects is illustrated.
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Addition of prefrontal rTMS eventuated in a significantly lower percentage of significant effects. In tinnitus, not 
only prefrontal areas, rather several cortical regions are involved, suggesting a widely spread network and also 
interindividual network profiles52–55. This postulation of several involved regions offers a putative approach to 
explain the unfavorable effect of additional prefrontal rTMS as only a “prefrontal” subtype would best benefit 
from this treatment and in other subtypes it might be contraindicative. Our finding of better effects of merely 
temporal stimulation provides support for the notion, that the final common pathway of tinnitus related patho-
physiological alterations might still be the auditory cortex56.
One might argue that initial positive findings of solely auditory cortex stimulation motivated the field to con-
centrate on this stimulation protocol and might have induced a publication bias in the sense that initial clinical 
trials are often reported as promising with large effect sizes followed by years of increasing frustration showing 
a decrease of effect sizes and an increase of negative trials. Our analysis indicates that there is no change in the 
number of significant studies published per year (see Fig. 3) not revealing a potential publication bias with a time 
trend.
Due to the limited amount of data we were only able to analyze the effects of single rTMS parameters alone. 
However, we are aware of the possibility of specific interactions of several parameters, as demonstrated by 
pulse-quantity-dependent after-effects of excitatory intermittent theta burst stimulation (iTBS) on MEPS to be 
more distinct after lower stimulation intensities57. Likewise, it may be possible, that the inequality in the number 
of significant (n = 56) and not significant (n = 18) study arms bears an influence on our results.
Howsoever, the role of stimulation intensities and pulses per session for the effectiveness of rTMS needs to 
be systematically examined to clarify the outstanding issues of dose-dependent effects in tinnitus trials, espe-
cially as these findings are contradictory to the experiences of rTMS for the treatment of depression58. One of 
the initial intentions of this review was to investigate the effect of different waveforms on the effectiveness of 
rTMS. Unfortunately, not a single study reported the used pulse waveform for the stimulation. We have therefore 
decided to statistically analyze the default waveform settings of the device. We found no significant association 
between the type of biphasic waveform and the significance level of the effect. It was stated, that the coil orien-
tation and the related induced direction of the currents are crucial in rTMS59–61. Biphasic pulses appear to be 
stronger, when passing the area of interest in anterior-posterior direction28. Due to many missing in the reported 
data, it was not possible to analyze the critical parameter current direction.
With the emerge of new technical innovations in the field of brain stimulation, exact stimulation positions via 
TMS integrated neuronavigation systems became a standard procedure. This review intended to determine the 
benefits of TMS neuronavigation systems in tinnitus. No such benefit is implied by our results. Either the local 
precision of stimulation does not play such a big role as presumed, or the targets were not optimally selected. 
Technical parameters like intensity or pulses, with neural mechanism not entirely understood, seem to be more 
important.
Several considerable methodological disadvantages were observed in the course of this review. A very impor-
tant parameter in order to compare outcomes of different studies and even specify the effectiveness of a specific 
intervention is the definition of a primary outcome. We identified a lack of this information in N = 36 study 
arms of interest, leading to an adapted definition of observed significance for our review. In the course of exam-
ining appropriate research papers, unexpected differences (e.g., breaks during stimulation) within the meth-
odology of 1 Hz rTMS were observed in some of the studies62–67. Such conditions make a comparison of trials 
even more difficult and introduce noise to the data. A major insight of the present work is the lack of reported 
essential rTMS parameters in the literature. Not only the full information about the used waveform was missing, 
but also relevant data on coil orientation or mean motor threshold features many missing values (cf. Table 2), 
which restricted our analysis. Guidelines for reporting e.g. the interventional methods used in clinical trials68 
rTMS Parameter
Significant 
Study Arms
Not Significant 
Study Arms
N N
Manufacturer TMS device — —
Pulse waveform 56 18
Default waveform — —
Coil type — 1
Coil orientation 22 12
Stimulation position 1 —
Stimulation hemisphere — 1
Stimulation frequency (%) 1 —
Stimulation intensity (%) 5 1
Mean motor threshold (%) 50 15
Motor threshold determination method 10 3
Number of sessions 1 —
Overall pulses per session over auditory and 
non—auditory cortical areas 1 —
Neuronavigation — —
Table 2. Missing data for rTMS parameters of 74 study arms.
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or a checklist for reporting parameters when deploying TMS on the motor system69 already exist. A paper from 
Wilson & St George70 and a recent review focusing on rTMS in the context of depression71 already emphasize 
the need of fully reported methodological information. The latter even provides a checklist for reporting rTMS 
parameters. Since both checklists enumerate essential parameters and details for rTMS, we strongly recommend 
their usage in future studies, to prospectively ensure a more precise and fundamental comparison of non-invasive 
brain stimulation studies using rTMS.
conclusion
The present systematic review demonstrates a higher efficacy of verum rTMS in contrast to sham rTMS. In verum 
arms, technical parameters such as stimulation intensity and number of pulses or restrictive stimulation of the 
auditory cortex were identified as relevant factors for clinical efficacy in a dose-dependent manner – less might 
be more. The impact of technical parameters in interaction with neurophysiological parameters (e.g., brain state 
before stimulation72–74) highlights the capability of rTMS in treating chronic tinnitus based on the premise to 
identify optimal stimulation protocols for single patients by means of personalized medical approaches75. In order 
to understand the consequences of considerable rTMS parameters in detail, standardized and sufficient report-
ing is highly required. As of yet, this is not the case – neither in tinnitus research nor in any other field utilizing 
rTMS24,25,45,49–51,62–67,75–119.
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